Co-Authors
This is a "connection" page, showing publications co-authored by Maria De Santis and Carlo Selmi.
Connection Strength
3.819
-
Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'. Ann Rheum Dis. 2021 Feb 16.
Score: 0.930
-
The elegance of a macrophage. Cell Mol Immunol. 2018 03; 15(3):196-198.
Score: 0.727
-
A case of psoriatic arthritis triggered by SARS-CoV-2 infection. Rheumatology (Oxford). 2021 01 05; 60(1):e21-e23.
Score: 0.231
-
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature. J Autoimmun. 2021 02; 117:102592.
Score: 0.230
-
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy. J Autoimmun. 2020 05; 109:102442.
Score: 0.219
-
Rheumatoid Factors in Hepatitis B and C Infections: Connecting Viruses, Autoimmunity, and Cancer. Isr Med Assoc J. 2019 Jul; 21(7):480-486.
Score: 0.208
-
The Role of Wnt Pathway in the Pathogenesis of OA and Its Potential Therapeutic Implications in the Field of Regenerative Medicine. Biomed Res Int. 2018; 2018:7402947.
Score: 0.198
-
Comment on: Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement. Semin Arthritis Rheum. 2019 02; 48(4):e23-e24.
Score: 0.190
-
How advances in personalized medicine will change rheumatology. Per Med. 2018 03; 15(2):75-78.
Score: 0.188
-
Detection of anti-mitochondrial antibodies by immunoprecipitation in patients with systemic sclerosis. J Immunol Methods. 2018 01; 452:1-5.
Score: 0.184
-
Personalized medicine in rheumatology: the paradigm of serum autoantibodies. Auto Immun Highlights. 2017 Dec; 8(1):10.
Score: 0.181
-
The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review. Clin Rev Allergy Immunol. 2017 Feb; 52(1):58-70.
Score: 0.176
-
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients. J Autoimmun. 2020 11; 114:102511.
Score: 0.056
-
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19. J Autoimmun. 2020 11; 114:102506.
Score: 0.055
-
ACUTE PHASE REACTIONS AFTER ZOLEDRONIC ACID INFUSION: PROTECTIVE ROLE OF 25-HYDROXYVITAMIN D AND PREVIOUS ORAL BISPHOSPHONATE THERAPY. Endocr Pract. 2018 May; 24(5):405-410.
Score: 0.047